{"entity":{"id":"nct07171606","kind":"trial","name":"A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients","aka":[],"tldr":"A phase 2 trial of SSGJ-706, Carboplatin and Pemetrexed in non-small-cell lung cancer, run by Shenyang Sunshine Pharmaceutical Co., LTD., now recruiting.","summary":"A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients is a phase 2 interventional study registered as NCT07171606 by Shenyang Sunshine Pharmaceutical Co., LTD., with 240 participants planned, started 2025-10-24 and due to reach its primary completion in 2026-08-31. Interventions recorded: SSGJ-706, pemetrexed /carboplatin, Carboplatin/Paclitaxel and PD-1 Inhibitor + Chemotherapy.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07171606","url":"https://clinicaltrials.gov/study/NCT07171606"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":["ssgj-706","carboplatin","pemetrexed"],"companies":["3sbio"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07171606","phase":"2","setting":"A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients","sponsor":"Shenyang Sunshine Pharmaceutical Co., LTD.","participation":[{"nct":"NCT07171606","source":"https://clinicaltrials.gov/study/NCT07171606","fetchedAt":"2026-10-07T16:55:29.886Z","studySha256":"6d0acde71b80aa3bfe25595248c50ad8ab080e913605febca1c1c6ee0882f1e7","overallStatus":"RECRUITING","lastUpdatePosted":"2025-12-18","leadSponsor":"Shenyang Sunshine Pharmaceutical Co., LTD.","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"75 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":240,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["China"]}],"started":"2025-10-24","startedType":"actual","enrolled":240,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07171606/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"drug":[{"id":"carboplatin","kind":"drug","name":"Carboplatin","route":"/drugs/carboplatin/"},{"id":"pemetrexed","kind":"drug","name":"Pemetrexed","route":"/drugs/pemetrexed/"},{"id":"ssgj-706","kind":"drug","name":"SSGJ-706","route":"/drugs/ssgj-706/"}],"company":[{"id":"3sbio","kind":"company","name":"3SBio","route":"/companies/3sbio/"}]}}